WKP|Q40258761

Search

Select Field:

Select Index:

Search Terms:

Leader		00000nz a2200037n 45 0
001		WKP\|Q40258761 (VIAF cluster) (Authority/Source Record)
003		WKP
005		20241221010712.0
008		241221nneanz\|\|abbn n and d
035		‎‡a (WKP)Q40258761‏
024		‎‡a 0000-0003-0504-0119‏ ‎‡2 orcid‏
035		‎‡a (OCoLC)Q40258761‏
100	0	‎‡a Jeong Hyun Lee‏ ‎‡9 ast‏ ‎‡9 es‏ ‎‡9 sl‏
400	0	‎‡a Jeong Hyun Lee‏ ‎‡c researcher (ORCID 0000-0003-0504-0119)‏ ‎‡9 en‏
670		‎‡a Author's 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors.‏
670		‎‡a Author's Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylatio‏
670		‎‡a Author's Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells‏
670		‎‡a Author's Cilostazol enhances neovascularization in the mouse hippocampus after transient forebrain ischemia‏
670		‎‡a Author's Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation‏
670		‎‡a Author's Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation‏
670		‎‡a Author's Gabapentin reduces infarct volume but does not suppress peri-infarct depolarizations‏
670		‎‡a Author's Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease‏
670		‎‡a Author's Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations‏
670		‎‡a Author's Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke‏
670		‎‡a Author's Neuroprotective effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378), a benzopyran analog, against focal ischemic brain damage in rats‏
670		‎‡a Author's Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.‏
670		‎‡a Author's Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis‏
670		‎‡a Author's Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation‏
670		‎‡a Author's Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD‏
670		‎‡a Author's Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol‏
670		‎‡a Author's Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents‏
670		‎‡a Author's Role of nitric oxide in the CBF autoregulation during acute stage after subarachnoid haemorrhage in rat pial artery‏
909		‎‡a (orcid) 0000000305040119‏ ‎‡9 1‏
919		‎‡a cilostazolpreventstumornecrosisfactoralphainducedcelldeathbysuppressionofphosphataseandtensinhomologdeletedfromchromosome10phosphorylationandactivationofaktcyclicampresponseelementbindingproteinphosphorylation‏ ‎‡A Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation‏ ‎‡9 1‏
919		‎‡a cilostazolsuppressessuperoxideproductionandexpressionofadhesionmoleculesinhumanendothelialcellsviamediationofcampdependentproteinkinasemediatedmaxikchannelactivation‏ ‎‡A Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation‏ ‎‡9 1‏
919		‎‡a gabapentinreducesinfarctvolumebutdoesnotsuppressperiinfarctdepolarizations‏ ‎‡A Gabapentin reduces infarct volume but does not suppress peri-infarct depolarizations‏ ‎‡9 1‏
919		‎‡a hypomorphicnotch3alleleslinknotchsignalingtoischemiccerebralsmallvesseldisease‏ ‎‡A Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease‏ ‎‡9 1‏
919		‎‡a migrainemutationsincreasestrokevulnerabilitybyfacilitatingischemicdepolarizations‏ ‎‡A Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations‏ ‎‡9 1‏
919		‎‡a multiparametriclongitudinalopticalcoherencetomographyimagingrevealsacuteinjuryandchronicrecoveryinexperimentalischemicstroke‏ ‎‡A Multiparametric, longitudinal optical coherence tomography imaging reveals acute injury and chronic recovery in experimental ischemic stroke‏ ‎‡9 1‏
919		‎‡a neuroprotectiveeffectof2s3s4rncyanon6amino34dihydro3hydroxy2methyl2dimethoxymethyl2hbenzopyran4ylnbenzylguanidinekr31378abenzopyrananalogagainstfocalischemicbraindamageinrats‏ ‎‡A Neuroprotective effect of (2S,3S,4R)-N"-cyano-N-(6-amino-3, 4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378), a benzopyran analog, against focal ischemic brain damage in rats‏ ‎‡9 1‏
919		‎‡a neuroprotectiveeffectofcilostazolagainstfocalcerebralischemiaviaantiapoptoticactioninrats‏ ‎‡A Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.‏ ‎‡9 1‏
919		‎‡a nutrientsensitizedscreeningfordrugsthatshiftenergymetabolismfrommitochondrialrespirationtoglycolysis‏ ‎‡A Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis‏ ‎‡9 1‏
919		‎‡a protectionfromapoptoticcelldeathbycilostazolphosphodiesterasetype3inhibitorviacampdependentproteinkinaseactivation‏ ‎‡A Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation‏ ‎‡9 1‏
919		‎‡a remnantlipoproteinparticlesinduceapoptosisinendothelialcellsbynad‏ ‎‡A Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD‏ ‎‡9 1‏
919		‎‡a roleofnitricoxideinthecbfautoregulationduringacutestageaftersubarachnoidhaemorrhageinratpialartery‏ ‎‡A Role of nitric oxide in the CBF autoregulation during acute stage after subarachnoid haemorrhage in rat pial artery‏ ‎‡9 1‏
919		‎‡a requisiteischemiaforspreadingdepolarizationoccurrenceaftersubarachnoidhemorrhageinrodents‏ ‎‡A Requisite ischemia for spreading depolarization occurrence after subarachnoid hemorrhage in rodents‏ ‎‡9 1‏
919		‎‡a remnantlipoproteinparticlesinduceapoptosisinendothelialcellsbynadphoxidasemediatedproductionofsuperoxideandcytokinesvialectinlikeoxidizedlowdensitylipoproteinreceptor1activationpreventionbycilostazol‏ ‎‡A Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol‏ ‎‡9 1‏
919		‎‡a 4substitutedquinazolinederivativesasnovelepha2receptortyrosinekinaseinhibitors‏ ‎‡A 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors.‏ ‎‡9 1‏
919		‎‡a antiapoptoticactionof2s3s4rncyanon6amino34dihydro3hydroxy2methyl2dimethoxymethyl2hbenzopyran4ylnbenzylguanidinekr31378bysuppressionofthephosphataseandtensinhomologdeletedfromchromosome10phosphorylatio‏ ‎‡A Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylatio‏ ‎‡9 1‏
919		‎‡a cilostazolenhancescaseinkinase2phosphorylationandsuppressestumornecrosisfactoralphainducedincreasedphosphataseandtensinhomologdeletedfromchromosome10phosphorylationandapoptoticcelldeathinsknshcells‏ ‎‡A Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells‏ ‎‡9 1‏
919		‎‡a cilostazolenhancesneovascularizationinthemousehippocampusaftertransientforebrainischemia‏ ‎‡A Cilostazol enhances neovascularization in the mouse hippocampus after transient forebrain ischemia‏ ‎‡9 1‏
996		‎‡2 ISNI\|0000000374061386‏
996		‎‡2 ISNI\|0000000460962949‏
996		‎‡2 ISNI\|0000000468684090‏
996		‎‡2 ISNI\|0000000467614744‏
996		‎‡2 LC\|no 94026370‏
996		‎‡2 LC\|no2024136879‏
996		‎‡2 ISNI\|0000000459418962‏
996		‎‡2 ISNI\|000000046839953X‏
996		‎‡2 ISNI\|0000000493071093‏
996		‎‡2 ISNI\|0000000505961801‏
996		‎‡2 ISNI\|0000000464632816‏
996		‎‡2 ISNI\|0000000468046427‏
996		‎‡2 ISNI\|0000000464311609‏
996		‎‡2 ISNI\|0000000479338281‏
996		‎‡2 ISNI\|0000000479150107‏
996		‎‡2 ISNI\|0000000504870414‏
996		‎‡2 CAOONL\|ncf11568996‏
996		‎‡2 ISNI\|0000000377491859‏
996		‎‡2 ISNI\|0000000512670324‏
996		‎‡2 ISNI\|0000000464526124‏
996		‎‡2 ISNI\|0000000493211981‏
996		‎‡2 ISNI\|0000000472518837‏
996		‎‡2 ISNI\|0000000494038113‏
996		‎‡2 ISNI\|0000000468723504‏
996		‎‡2 ISNI\|0000000479131782‏
996		‎‡2 ISNI\|0000000360458016‏
996		‎‡2 BNF\|12536294‏
996		‎‡2 DNB\|1158835957‏
996		‎‡2 SUDOC\|144497018‏
996		‎‡2 BIBSYS\|90362303‏
996		‎‡2 SUDOC\|11700832X‏
996		‎‡2 LC\|nb2016010291‏
996		‎‡2 J9U\|987007338541105171‏
996		‎‡2 ISNI\|0000000480115480‏
996		‎‡2 ISNI\|0000000479342985‏
996		‎‡2 ISNI\|0000000465145980‏
996		‎‡2 ISNI\|0000000516740705‏
996		‎‡2 ISNI\|0000000474060364‏
996		‎‡2 SUDOC\|243616120‏
996		‎‡2 ISNI\|0000000504858183‏
996		‎‡2 RERO\|A008954306‏
996		‎‡2 ISNI\|0000000505781421‏
996		‎‡2 CAOONL\|ncf11527894‏
996		‎‡2 J9U\|987007312475405171‏
996		‎‡2 ISNI\|0000000460253704‏
996		‎‡2 J9U\|987007321563305171‏
996		‎‡2 LC\|n 84218241‏
996		‎‡2 ISNI\|0000000464840324‏
996		‎‡2 ISNI\|000000046487943X‏
996		‎‡2 ISNI\|000000046000402X‏
996		‎‡2 DNB\|1299484646‏
996		‎‡2 ISNI\|0000000474011474‏
996		‎‡2 ISNI\|0000000509855256‏
996		‎‡2 ISNI\|0000000473514010‏
996		‎‡2 ISNI\|0000000467869544‏
996		‎‡2 ISNI\|0000000493004202‏
996		‎‡2 ISNI\|0000000480268559‏
996		‎‡2 DNB\|135824435‏
996		‎‡2 ISNI\|0000000036235005‏
996		‎‡2 ISNI\|0000000461082687‏
996		‎‡2 ISNI\|0000000461106220‏
996		‎‡2 LC\|n 98923285‏
996		‎‡2 ISNI\|0000000505659119‏
996		‎‡2 J9U\|987007297153905171‏
996		‎‡2 ISNI\|0000000502850583‏
996		‎‡2 ISNI\|0000000480268399‏
996		‎‡2 ISNI\|0000000505386202‏
996		‎‡2 ISNI\|0000000473955713‏
996		‎‡2 ISNI\|0000000491938298‏
996		‎‡2 ISNI\|0000000468704995‏
996		‎‡2 ISNI\|0000000460308648‏
996		‎‡2 ISNI\|0000000480115042‏
996		‎‡2 ISNI\|0000000513331869‏
996		‎‡2 BNC\|981058525074806706‏
996		‎‡2 ISNI\|0000000468025415‏
996		‎‡2 ISNI\|0000000473693661‏
996		‎‡2 ISNI\|0000000463342825‏
996		‎‡2 ISNI\|0000000467848102‏
996		‎‡2 ISNI\|0000000493304694‏
996		‎‡2 ISNI\|000000046340650X‏
996		‎‡2 ISNI\|0000000476386878‏
996		‎‡2 PLWABN\|9810694397805606‏
996		‎‡2 ISNI\|0000000468723467‏
996		‎‡2 ISNI\|0000000514351917‏
996		‎‡2 ISNI\|0000000494048100‏
996		‎‡2 ISNI\|0000000460182619‏
996		‎‡2 CAOONL\|ncf10882333‏
996		‎‡2 LC\|nb2010014033‏
996		‎‡2 ISNI\|0000000507238369‏
996		‎‡2 BNF\|16617152‏
996		‎‡2 ISNI\|0000000467075429‏
996		‎‡2 ISNI\|0000000074783088‏
996		‎‡2 ISNI\|000000049224751X‏
996		‎‡2 ISNI\|0000000467788250‏
996		‎‡2 J9U\|987012492554205171‏
996		‎‡2 NLA\|000051673588‏
996		‎‡2 ISNI\|0000000468156108‏
996		‎‡2 ISNI\|0000000513489869‏
996		‎‡2 ISNI\|0000000464718791‏
996		‎‡2 ISNI\|000000046768702X‏
996		‎‡2 ISNI\|0000000478989496‏
996		‎‡2 ISNI\|0000000477192346‏
996		‎‡2 ISNI\|0000000514394044‏
996		‎‡2 ISNI\|0000000463565949‏
996		‎‡2 ISNI\|0000000038222283‏
996		‎‡2 ISNI\|0000000505519562‏
996		‎‡2 ISNI\|0000000473388691‏
996		‎‡2 ISNI\|0000000505228140‏
996		‎‡2 ISNI\|0000000479041816‏
996		‎‡2 ISNI\|0000000461039590‏
996		‎‡2 ISNI\|0000000504603316‏
996		‎‡2 ISNI\|0000000493250702‏
996		‎‡2 ISNI\|0000000477154892‏
996		‎‡2 LC\|n 2009041025‏
996		‎‡2 ISNI\|0000000494051270‏
996		‎‡2 ISNI\|000000049323127X‏
996		‎‡2 ISNI\|0000000472369245‏
996		‎‡2 ISNI\|0000000468001544‏
996		‎‡2 ISNI\|000000045944938X‏
996		‎‡2 DNB\|138060606‏
996		‎‡2 ISNI\|000000046870766X‏
996		‎‡2 ISNI\|0000000055578054‏
996		‎‡2 ISNI\|0000000463230292‏
996		‎‡2 J9U\|987012501824905171‏
996		‎‡2 LC\|no2024071248‏
996		‎‡2 SUDOC\|243280955‏
996		‎‡2 ISNI\|0000000465073702‏
996		‎‡2 ISNI\|0000000504729883‏
996		‎‡2 ISNI\|0000000468052691‏
996		‎‡2 CAOONL\|ncf10309384‏
996		‎‡2 SUDOC\|181425777‏
996		‎‡2 ISNI\|0000000468701380‏
996		‎‡2 BIBSYS\|1634281498417‏
996		‎‡2 LC\|n 2001098653‏
996		‎‡2 ISNI\|0000000512340456‏
996		‎‡2 ISNI\|0000000479018368‏
996		‎‡2 ISNI\|0000000493271060‏
996		‎‡2 ISNI\|0000000505707600‏
996		‎‡2 ISNI\|0000000456017434‏
996		‎‡2 ISNI\|0000000473876484‏
996		‎‡2 ISNI\|0000000464870304‏
996		‎‡2 ISNI\|0000000463230188‏
996		‎‡2 ISNI\|000000008333839X‏
996		‎‡2 ISNI\|0000000505763266‏
996		‎‡2 ISNI\|0000000513465998‏
996		‎‡2 NUKAT\|n 2022075785‏
996		‎‡2 ISNI\|0000000439744226‏
996		‎‡2 ISNI\|0000000505553162‏
996		‎‡2 LC\|no2022018177‏
996		‎‡2 ISNI\|0000000479338337‏
996		‎‡2 BNF\|15080686‏
996		‎‡2 ISNI\|000000047394810X‏
996		‎‡2 RERO\|A027349639‏
996		‎‡2 ISNI\|0000000459467836‏
996		‎‡2 DNB\|1157922341‏
996		‎‡2 LC\|n 2023043652‏
996		‎‡2 ISNI\|0000000393661344‏
996		‎‡2 ISNI\|0000000477048520‏
996		‎‡2 LC\|nb2015000348‏
996		‎‡2 ISNI\|0000000463372223‏
996		‎‡2 ISNI\|0000000474023643‏
996		‎‡2 SUDOC\|268658633‏
996		‎‡2 NUKAT\|n 2012112630‏
996		‎‡2 CAOONL\|ncf11540116‏
996		‎‡2 ISNI\|0000000467709815‏
996		‎‡2 LC\|no 00013592‏
996		‎‡2 ISNI\|000000006547569X‏
996		‎‡2 ISNI\|0000000504944540‏
996		‎‡2 PLWABN\|9812461800205606‏
996		‎‡2 ISNI\|0000000464797004‏
996		‎‡2 LC\|n 2008066233‏
996		‎‡2 ISNI\|0000000464625288‏
996		‎‡2 DNB\|136225969‏
996		‎‡2 LC\|no2021117822‏
996		‎‡2 DNB\|1034564331‏
996		‎‡2 RERO\|A017816737‏
996		‎‡2 ISNI\|0000000477653835‏
996		‎‡2 BIBSYS\|90232234‏
996		‎‡2 ISNI\|0000000463285322‏
996		‎‡2 ISNI\|0000000504501678‏
996		‎‡2 ISNI\|0000000465124047‏
996		‎‡2 ISNI\|0000000513642392‏
996		‎‡2 ISNI\|0000000467685104‏
996		‎‡2 ISNI\|0000000480114736‏
996		‎‡2 ISNI\|0000000491609291‏
996		‎‡2 ISNI\|0000000512760186‏
996		‎‡2 ISNI\|0000000473870082‏
996		‎‡2 ISNI\|000000047917765X‏
996		‎‡2 ISNI\|0000000464462239‏
996		‎‡2 SUDOC\|147906083‏
996		‎‡2 ISNI\|0000000492252394‏
996		‎‡2 J9U\|987007526401105171‏
996		‎‡2 ISNI\|0000000468697609‏
996		‎‡2 ISNI\|000000051232865X‏
996		‎‡2 ISNI\|0000000464369915‏
996		‎‡2 ISNI\|0000000507260486‏
996		‎‡2 BNC\|981058612158406706‏
996		‎‡2 ISNI\|0000000502806822‏
996		‎‡2 ISNI\|0000000503875360‏
996		‎‡2 ISNI\|0000000473760852‏
996		‎‡2 ISNI\|0000000474076235‏
996		‎‡2 ISNI\|0000000053743896‏
996		‎‡2 ISNI\|0000000516714718‏
996		‎‡2 LC\|n 2005067143‏
996		‎‡2 ISNI\|0000000492134259‏
996		‎‡2 NUKAT\|n 2021211152‏
996		‎‡2 ISNI\|0000000477366676‏
996		‎‡2 ISNI\|000000046870117X‏
996		‎‡2 SUDOC\|136478441‏
996		‎‡2 ISNI\|0000000478981689‏
996		‎‡2 ISNI\|000000051317754X‏
996		‎‡2 ISNI\|000000049250028X‏
996		‎‡2 LC\|no2007034554‏
996		‎‡2 ISNI\|000000046484232X‏
996		‎‡2 ISNI\|0000000513455474‏
996		‎‡2 ISNI\|0000000475154047‏
996		‎‡2 ISNI\|0000000468731432‏
996		‎‡2 ISNI\|0000000514811493‏
996		‎‡2 ISNI\|000000050416072X‏
996		‎‡2 ISNI\|0000000477759939‏
996		‎‡2 ISNI\|0000000463404168‏
996		‎‡2 ISNI\|0000000463387169‏
996		‎‡2 ISNI\|0000000480115616‏
996		‎‡2 LC\|no2010033193‏
996		‎‡2 SUDOC\|233221492‏
996		‎‡2 ISNI\|0000000479186265‏
996		‎‡2 ISNI\|0000000460470282‏
996		‎‡2 ISNI\|0000000461082783‏
996		‎‡2 SUDOC\|069036438‏
996		‎‡2 NTA\|242837700‏
996		‎‡2 ISNI\|0000000493152918‏
996		‎‡2 DNB\|171587847‏
996		‎‡2 CAOONL\|ncf10119647‏
996		‎‡2 ISNI\|0000000473748976‏
996		‎‡2 ISNI\|0000000468716814‏
996		‎‡2 ISNI\|0000000381538402‏
996		‎‡2 ISNI\|0000000461033906‏
996		‎‡2 ISNI\|0000000464631135‏
996		‎‡2 DBC\|87097991345153‏
996		‎‡2 ISNI\|0000000468577930‏
996		‎‡2 BIBSYS\|90150658‏
996		‎‡2 ISNI\|0000000514736024‏
996		‎‡2 ISNI\|0000000463360513‏
996		‎‡2 LC\|n 2023070471‏
996		‎‡2 BIBSYS\|90386639‏
996		‎‡2 ISNI\|0000000474839685‏
996		‎‡2 ISNI\|0000000476494238‏
996		‎‡2 ISNI\|0000000506611918‏
996		‎‡2 PLWABN\|9813998095405606‏
996		‎‡2 ISNI\|0000000477195416‏
997		‎‡a 0 0 lived 0 0‏ ‎‡9 1‏

VIAF

Virtual International Authority File

Search